Xerion Healthcare Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $308K
Latest Deal Amount
  • Investors
  • 5

Xerion Healthcare General Information

Description

Provider of nanomedicine technology intended to improve the effectiveness of conventional radiotherapy while minimizing side-effects. The company's technology is based on titanium dioxide a common, non-toxic, semiconductor material that is injected into tumors just prior to standard radiotherapy which enhances the effectiveness of the treatment, amplifying the dose of free radicals generated by the X-rays, enabling medical professionals to treat dense tumors and accumulates in tumor cells.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Drug Discovery
Primary Office
  • Cherwell Innovation Centre
  • 77 Heyford Park, Upper Heyford
  • Oxfordshire OX25 5HD
  • England, United Kingdom
+44 01869 000000

Xerion Healthcare Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xerion Healthcare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 03-Nov-2021 $308K 00.000 00.000 Completed Generating Revenue
6. Later Stage VC (Series A) 08-Apr-2020 00000 00.000 00000 Completed Generating Revenue
5. Grant 20-Sep-2019 00000 00.000 Completed Generating Revenue
4. Later Stage VC (Series A) 14-Mar-2018 00.000 00.000 00.00 Completed Generating Revenue
3. Grant 24-Mar-2017 00000 00.000 Completed Generating Revenue
2. Early Stage VC 17-Oct-2016 $530K $2.87M 00.000 Completed Startup
1. Early Stage VC 24-Aug-2015 $2.34M $2.34M 00.00 Completed Startup
To view Xerion Healthcare’s complete valuation and funding history, request access »

Xerion Healthcare Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 560,320 $0.001369 $2.85 $2.85 1x $2.85 22.92%
To view Xerion Healthcare’s complete cap table history, request access »

Xerion Healthcare Patents

Xerion Healthcare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201719076-D0 Particles for the treatment of cancer in combination with radiotherapy Ceased 17-Nov-2017 0000000000
JP-2021503492-A Particles for treating cancer in combination with radiation therapy Pending 17-Nov-2017 00000000000
US-20200276230-A1 Particles for the treatment of cancer in combination with radiotherapy Pending 17-Nov-2017 00000000000
EP-3710056-A1 Particles for the treatment of cancer in combination with radiotherapy Pending 17-Nov-2017 A61K33/244

Xerion Healthcare Executive Team (3)

Name Title Board Seat Contact Info
Ian George Ph.D Chief Executive Officer & Board Member
Gareth Wakefield Ph.D Co-Founder, Chief Technology Officer & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

Xerion Healthcare Board Members (5)

Name Representing Role Since
Gareth Wakefield Ph.D Xerion Healthcare Co-Founder, Chief Technology Officer & Board Member 000 0000
Ian George Ph.D Xerion Healthcare Chief Executive Officer & Board Member 000 0000
Justin Stebbing Ph.D Self Chairman 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Xerion Healthcare Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xerion Healthcare Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
New Wave Ventures Venture Capital Minority 000 0000 000000 0
Oxford Science Enterprises University Minority 000 0000 000000 0
Oxford Spin-out Equity Management Venture Capital Minority 000 0000 000000 0
Parkwalk Advisors Venture Capital Minority 000 0000 000000 0
To view Xerion Healthcare’s complete investors history, request access »